Stocks · Health care · Pharmaceutical Preparations

Altimmune, Inc.

ALT Clue Score41
United States Fiscal year ends December CIK 0001326190 Results filed 12 Aug 2026

What the insiders did No buying or selling

By person

12 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Vipin K Garg
Director
—
—
—
424,519
$1.25M
+45.4%
M Scot Roberts
Chief Scientific Officer
—
—
—
113,699
$335.41K
+162.5%
Raymond M Jordt
Chief Business Officer
—
—
—
70,107
$206.82K
+378.2%
Jerome Benedict Durso
President and CEO
—
—
—
62,500
$184.38K
—
Gregory L Weaver
Chief Financial Officer
—
—
—
49,927
$147.28K
—
Christophe Arbet-Engels
Chief Medical Officer
—
—
—
24,821
$73.22K
—
John Gill
Director
—
—
—
21,700
$64.02K
—
Linda M Richardson
Chief Commercial Officer
—
—
—
17,174
$50.66K
—
Matthew Scott Harris
Chief Medical Officer
—
—
—
16,087
$47.46K
−70.8%
Wayne Pisano
Director
—
—
—
13,498
$39.82K
+58.8%
Catherine A. Sohn
Director
—
—
—
1,500
$4.43K
—
Diane Jorkasky
Director
—
—
—
527
$1.55K
—

No percentages here. This company's share count has moved by a factor of 2.5 over the window, from 77,013,658 to 194,517,701 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.